Alvaro
Lassaletta Atienza
Consultor Médico
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (5)
2020
-
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042
-
Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-15
2017
-
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy
Annals of Hematology, Vol. 96, Núm. 9, pp. 1449-1456
2016
-
Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells
Cancer Letters, Vol. 371, Núm. 2, pp. 161-170
2015
-
Chemokines and relapses in childhood acute lymphoblastic leukemia: A role in migration and in resistance to antileukemic drugs
Blood Cells, Molecules, and Diseases, Vol. 55, Núm. 3, pp. 220-227